Balani, S.K., C. Lu, K. Cardoza, C. Berg and J. Zhang, et al., 2008. Proposed new addition to 3Rs for ethical and humane use of rats in pharmacokinetic studies-'Recycle'. Drug Metab. Lett., 2: 193-197.
PubMed  |  Direct Link  |  

Balani, S.K., N.V. Nagaraja, M.G. Qian, A.O. Costa and J.S. Daniels, et al., 2006. Evaluation of microdosing to assess pharmacokinetic linearity in rats using liquid chromatography-tandem mass spectrometry. Drug Metab. Dispos., 34: 384-388.
PubMed  |  Direct Link  |  

Blackburn, C., B. Guan, J. Brown, C. Cullis and S.M. Condon, et al., 2006. Identification and characterization of 4-aryl-3,4-dihydropyrimidin-2(1H)-ones as inhibitors of the fatty acid transporter FATP4. Bioorg. Med. Chem. Lett., 16: 3504-3509.
PubMed  |  Direct Link  |  

Li, P., C. Lu, S.K. Balani and L.S. Gan, 2011. A refined cytochrome P540 IC₅₀shift assay for reliably identifying CYP3A time-dependent inhibitors. Drug Metab. Dispos., 39: 1054-1057.
PubMed  |  Direct Link  |  

Li, P., P.S. Callery, L.S. Gan and S.K. Balani, 2007. Esterase inhibition attribute of grapefruit juice leading to a new drug interaction. Drug Metab. Dispos., 35: 1023-1031.
CrossRef  |  Direct Link  |  

Li, P., P.S. Callery, L.S. Gan and S.K. Balani, 2007. Esterase inhibition by grapefruit juice flavonoids leading to a new drug interaction. Drug Metab. Dispos., 35: 1203-1208.
PubMed  |  Direct Link  |  

Liao, M., A.R. Raczynski, M. Chen, B.C. Chuang and Q. Zhu, et al., 2010. Inhibition of hepatic organic anion-transporting polypeptide by RNA interference in sandwich-cultured human hepatocytes: an in vitro model to assess transporter-mediated drug-drug interactions. Drug Metab. Dispos., 38: 1612-1622.
PubMed  |  Direct Link  |  

Lu, C., C. Berg, S.R. Prakash, F.W. Lee and S.K. Balani, 2008. Prediction of pharmacokinetic drug-drug interactions using human hepatocyte suspension in plasma and cytochrome P450 phenotypic data. III. In vitro-in vivo correlation with fluconazole. Drug Metab. Dispos., 36: 1261-1266.
PubMed  |  Direct Link  |  

Lu, C., G.T. Miwa, S.R. Prakash, L. Gan and S.K. Balani, 2006. A novel model for the prediction of drug-drug interactions in humans based on in vitro Cytochrome P450 phenotypic data. Drug Metab. Dispos., 35: 79-85.
CrossRef  |  Direct Link  |  

Lu, C., P. Hatsis, C. Berg, F.W. Lee and S.K. Balani, 2008. Prediction of pharmacokinetic drug-drug interactions using human hepatocyte suspension in plasma and cytochrome P450 phenotypic data. II. In vitro-in vivo correlation with ketoconazole. Drug Metab. Dispos., 36: 1255-1260.
Direct Link  |  

Lu, C., P. Li, R. Gallegos, V. Uttamsingh and C.Q. Xia, et al., 2006. Comparison of intrinsic clearance in liver microsomes and hepatocytes from rats and humans: evaluation of free fraction and uptake in hepatocytes. Drug Metab. Dispos., 34: 1600-1605.
CrossRef  |  Direct Link  |  

Lu, C., S.K. Balani, M.G. Qian, S.R. Prakash and P.S. Ducray, et al., 2010. Quantitative prediction and clinical observation of a CYP3A inhibitor-based drug-drug interactions with MLN3897, a potent C-C chemokine receptor-1 antagonist. J. Pharmacol. Exp. Ther., 332: 562-568.
PubMed  |  Direct Link  |  

Manfredi, M.G., J.A. Ecsedy, K.A. Meetze, S.K. Balani and O. Burenkova, 2007. Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase. Proc. Natl. Acad. Sci., 104: 4106-4111.
CrossRef  |  Direct Link  |  

Vos, T.J., S. Balani, C. Blackburn, R.W. Chau and M.D. Danca, et al., 2006. Identification and structure-activity relationships of a new series of Melanocortin-4 receptor antagonists. Bioorg. Med. Chem. Lett., 16: 2302-2305.
CrossRef  |  PubMed  |  Direct Link  |  

Yang, J.J., M.N. Milton, S. Yu, M. Liao and N. Liu, et al., 2010. P-glycoprotein and breast cancer resistance protein affect disposition of tandutinib, a tyrosine kinase inhibitor. Drug Metab. Lett., 4: 201-212.
PubMed  |  Direct Link  |  

Yin, W., L.S. Gan, J.T. Wu, S.K. Balani and H. Yang, et al., 2007. An indirect screen for brain uptake of 1,2-diarylethane melanocortin 4 receptor antagonists in rats. Drug Metab. Lett., 1: 195-198.
CrossRef  |  PubMed  |  Direct Link  |